Red LED photobiomodulation reduces pain hypersensitivity and improves sensorimotor function following mild T10 hemicontusion spinal cord injury

dc.contributor.authorHu, Di
dc.contributor.authorZhu, Shuyu
dc.contributor.authorPotas, Jason R
dc.date.accessioned2016-08-29T00:17:18Z
dc.date.available2016-08-29T00:17:18Z
dc.date.issued2016-08-26
dc.date.updated2016-08-26T06:24:31Z
dc.description.abstractBACKGROUND The development of hypersensitivity following spinal cord injury can result in incurable persistent neuropathic pain. Our objective was to examine the effect of red light therapy on the development of hypersensitivity and sensorimotor function, as well as on microglia/macrophage subpopulations following spinal cord injury. METHODS Wistar rats were treated (or sham treated) daily for 30 min with an LED red (670 nm) light source (35 mW/cm2), transcutaneously applied to the dorsal surface, following a mild T10 hemicontusion injury (or sham injury). The development of hypersensitivity was assessed and sensorimotor function established using locomotor recovery and electrophysiology of dorsal column pathways. Immunohistochemistry and TUNEL were performed to examine cellular changes in the spinal cord. RESULTS We demonstrate that red light penetrates through the entire rat spinal cord and significantly reduces signs of hypersensitivity following a mild T10 hemicontusion spinal cord injury. This is accompanied with improved dorsal column pathway functional integrity and locomotor recovery. The functional improvements were preceded by a significant reduction of dying (TUNEL+) cells and activated microglia/macrophages (ED1+) in the spinal cord. The remaining activated microglia/macrophages were predominantly of the anti-inflammatory/wound-healing subpopulation (Arginase1+ED1+) which were expressed early, and up to sevenfold greater than that found in sham-treated animals. CONCLUSIONS These findings demonstrate that a simple yet inexpensive treatment regime of red light reduces the development of hypersensitivity along with sensorimotor improvements following spinal cord injury and may therefore offer new hope for a currently treatment-resistant pain condition.en_AU
dc.description.sponsorshipThis study was funded by the Gretel and Gordon Bootes Medical Research Foundation.en_AU
dc.format15 pagesen_AU
dc.identifier.citation13(1):200en_AU
dc.identifier.issn1742-2094en_AU
dc.identifier.urihttp://dx.doi.org/10.1186/s12974-016-0679-3
dc.identifier.urihttp://hdl.handle.net/1885/107328
dc.language.rfc3066en
dc.publisherBioMed Centralen_AU
dc.rights© 2016 The Author(s). Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.en_AU
dc.rights.holderThe Author(s).
dc.sourceJournal of Neuroinflammationen_AU
dc.subjectPhotobiomodulationen_AU
dc.subjectLight therapyen_AU
dc.subjectM2 macrophage polarizationen_AU
dc.subjectAllodyniaen_AU
dc.subjectNeuropathic painen_AU
dc.subject670 nmen_AU
dc.titleRed LED photobiomodulation reduces pain hypersensitivity and improves sensorimotor function following mild T10 hemicontusion spinal cord injuryen_AU
dc.typeJournal articleen_AU
dcterms.accessRightsOpen Accessen_AU
dcterms.dateAccepted2016-08-17
local.bibliographicCitation.startpage200en_AU
local.contributor.affiliationPotas, Jason R., Eccles Institute of Neuroscience, CMBE John Curtin School of Medical Research, the Australian National Universityen_AU
local.contributor.affiliationHu, Di., The John Curtin School of Medical Research, The Australian National Universityen_AU
local.contributor.affiliationZhu, Shuyu, The John Curtin School of Medical Research, The Australian National Universityen_AU
local.contributor.authoremailjason.potas@anu.edu.auen_AU
local.contributor.authoruidu3548688en_AU
local.identifier.ariespublicationa383154xPUB4271
local.identifier.citationvolume13en_AU
local.identifier.doi10.1186/s12974-016-0679-3en_AU
local.identifier.essn1742-2094en_AU
local.identifier.uidSubmittedByu4579722en_AU
local.publisher.urlhttp://www.biomedcentral.com/en_AU
local.type.statusPublished Versionen_AU

Downloads

Original bundle

Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
12974_2016_Article_679.pdf
Size:
3.07 MB
Format:
Adobe Portable Document Format

License bundle

Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
884 B
Format:
Item-specific license agreed upon to submission
Description: